TendoNova Logo.jpg
TendoNova Inks Partnership with AcCELLerated Biologics
March 08, 2023 09:25 ET | TendoNova
ATLANTA, March 08, 2023 (GLOBE NEWSWIRE) -- TendoNova, an emerging leader in micro-invasive sports medicine procedures, is pleased to announce that it has reached an agreement with AcCELLerated...
TendoNova Logo.jpg
TendoNova Receives GRA Phase III Commercialization Funding
August 05, 2021 10:32 ET | TendoNova
ATLANTA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- TendoNova Corporation is pleased to announce that it has been selected for the Georgia Research Alliance (GRA) Phase III commercialization program. The...
TendoNova Logo.jpg
TendoNova Appoints Mark A. Samuels as CEO
October 14, 2020 08:58 ET | TendoNova
ATLANTA, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Atlanta-based TendoNova Corporation is pleased to announce the appointment of Mark A. Samuels as Chief Executive Officer effective September 9th, 2020. Mr....
TendoNova Logo.jpg
NFLPA Invests in TendoNova to Develop Devices that Enable Microinvasive Orthopedic Procedures
June 11, 2020 07:00 ET | TendoNova
ATLANTA, June 11, 2020 (GLOBE NEWSWIRE) -- The NFL Players Association (NFLPA), through its for-profit subsidiary NFL Players Inc., has invested in TendoNova™ Corporation. TendoNova is an...
TendoNova Logo.jpg
TendoNova Presents on the National Stage at NFL ‘1st and Future’
February 06, 2019 07:54 ET | TendoNova
ATLANTA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- TendoNova™ Corporation was one of just five companies chosen to present on the national stage as a finalist for the 2019 NFL’s “1st and Future” competition...